TrialThe American journal of gastroenterology2020

Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.

Hyung Joon Yim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.